Skip to main content
ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.220
+0.180 (8.82%)
Apr 28, 2026, 4:31 PM CET

STO:EXPRS2 Revenue

ExpreS2ion Biotech Holding AB had revenue of 3.53M SEK in the quarter ending December 31, 2025, with 62.21% growth. This brings the company's revenue in the last twelve months to 10.85M, up 36.83% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.

Revenue (ttm)
10.85M
Revenue Growth
+36.83%
P/S Ratio
0.72
Revenue / Employee
542.60K
Employees
20
Market Cap
7.84M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20247.83M-974.00K-11.07%
Dec 31, 20238.80M2.65M43.07%
Dec 31, 20226.15M-7.58M-55.21%
Dec 31, 202113.73M-1.53M-10.04%
Dec 31, 202015.26M1.43M10.37%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Aptahem AB 2.59M
Fluicell AB 15.22M
NanoEcho AB 487.00K
Biosergen AB 2.09M
Stayble Therapeutics AB 47.00K
Lipigon Pharmaceuticals AB 74.00K
2cureX AB 1.98M
Alzinova AB 26.80M
Revenue Rankings

ExpreS2ion Biotech Holding AB News

More News